References
- O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373:1891–1904.10.1016/S0140-6736(09)60327-5
- Cardines R, Giufrè M, Pompilio A, et al. Haemophilus influenzae in children with cystic fibrosis: antimicrobial susceptibility, molecular epidemiology, distribution of adhesins and biofilm formation. Int. J. Med. Microbiol. 2012;302:45–52.10.1016/j.ijmm.2011.08.003
- Razvi S, Quittell L, Sewall A, et al. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest. 2009;136:1554–1560.10.1378/chest.09-0132
- Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 2002;15:194–222.10.1128/CMR.15.2.194-222.2002
- Phaff SJ, Tiddens HAWM, Verbrugh HA, et al. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. J. Antimicrob. Chemother. 2006;57:741–746.10.1093/jac/dkl014
- Häuβler S, Ziegler I, Löttel A, et al. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J. Med. Microbiol. 2003;52:295–301.
- Román F, Cantón R, Pérez-Vázquez M, et al. Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains. J. Clin. Microbiol. 2004;42:1450–1459.10.1128/JCM.42.4.1450-1459.2004
- Witherden EA, Tristram SG. Prevalence and mechanisms of β-lactam resistance in Haemophilus haemolyticus. J. Antimicrob. Chemother. 2013;68:1049–1053.10.1093/jac/dks532
- Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin. Microbiol. Rev. 2007;20:368–389.10.1128/CMR.00040-06
- Hasegawa K, Chiba N, Kobayashi R, et al. Rapidly increasing prevalence of β-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother. 2004;48:1509–1514.10.1128/AAC.48.5.1509-1514.2004
- Witherden EA, Montgomery J, Henderson B, et al. Prevalence and genotypic characteristics of β-lactamase-negative ampicillin-resistant Haemophilus influenzae in Australia. J. Antimicrob. Chemother. 2011;66:1013–1015.10.1093/jac/dkr035
- The European Committee on antimicrobial susceptibility testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. [cited 2015 Jan 1]. Available from: http://www.eucast.org.
- Pérez-Vázquez M, Román F, Aracil B, et al. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to gyrA and parC mutations. J. Clin. Microbiol. 2004;42:1185–1191.10.1128/JCM.42.3.1185-1191.2004